Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rovalpituzumab tesirine and DLL3: a new challenge for small-cell lung cancer.

× No keyword cloud information.

5 in total

1. [Over-expression of human Notch ligand Delta-like 3 promotes proliferation of human gastric cancer cells in vitro].

Authors: Bingxin Hu; Jianbin Ye; Xiaomei Qiu; Yanqing Lin; Danlin Wu; Junjie Wen; Meiqun Luo; Lijun Ning; Yan Li; Yunshan Ning
Journal: Nan Fang Yi Ke Da Xue Xue Bao Date: 2018-01-30

Review 2. New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.

Authors: Isabel Corraliza-Gorjón; Beatriz Somovilla-Crespo; Silvia Santamaria; Jose A Garcia-Sanz; Leonor Kremer
Journal: Front Immunol Date: 2017-12-21 Impact factor: 7.561

3. Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs).

Authors: Ricarda M Hoffmann; Ben G T Coumbe; Debra H Josephs; Silvia Mele; Kristina M Ilieva; Anthony Cheung; Andrew N Tutt; James F Spicer; David E Thurston; Silvia Crescioli; Sophia N Karagiannis
Journal: Oncoimmunology Date: 2017-11-20 Impact factor: 8.110

Review 4. Comparison and discussion of the treatment guidelines for small cell lung cancer.

Authors: Honglin Zhao; Dian Ren; Hongyu Liu; Jun Chen
Journal: Thorac Cancer Date: 2018-05-16 Impact factor: 3.500

5. Potential prognostic value of delta-like protein 3 in small cell lung cancer: a meta-analysis.

Authors: Benchao Chen; Heng Li; Chao Liu; Shuting Wang; Feiyue Zhang; Li Zhang; Mingjie Li; Gaofeng Li
Journal: World J Surg Oncol Date: 2020-08-26 Impact factor: 2.754

5 in total